Our team recently demonstrated a significant inhibition of tumor growth in a mouse xenograft model of HER2-overexpressing breast cancer, using functionalized gold nanoparticles with anti-HER-2 antibodies [93]. This evidence concerns the gene ERBB2 and breast cancer.